Triple

Target class: oral suspension formulation of edaravone
Context triple: [Radicava ORS, instanceOf, oral suspension formulation of edaravone]

• A. reversal agent for factor Xa inhibitors
  A reversal agent for factor Xa inhibitors is a therapeutic substance designed to rapidly neutralize the anticoagulant effects of factor Xa–inhibiting drugs in situations such as life-threatening bleeding or urgent surgery.
• B. pegylated interferon beta-1a
  Pegylated interferon beta-1a is a long-acting, pegylated form of interferon used as a disease-modifying therapy to reduce relapses and slow progression in patients with relapsing forms of multiple sclerosis.
• C. Ebola virus disease treatment
  Ebola virus disease treatment encompasses the medical interventions, supportive care, and infection control measures used to manage symptoms, reduce mortality, and prevent transmission of the Ebola virus in infected individuals.
• D. calcitonin gene-related peptide inhibitor
  A calcitonin gene-related peptide inhibitor is a drug that blocks the activity or receptor of CGRP, a neuropeptide involved in migraine and pain signaling, to prevent or reduce migraine attacks.
• E. AAV9-based gene therapy
  AAV9-based gene therapy is a treatment approach that uses adeno-associated virus serotype 9 vectors to deliver therapeutic genes into patient cells, often targeting the central nervous system, muscle, or other tissues for long-term expression.
• F. None of above. chosen